Masimo (MASI) Competitors

$136.14
+0.90 (+0.67%)
(As of 04/26/2024 ET)

MASI vs. ITGR, LIVN, TMDX, CNMD, INSP, VKTX, ITCI, GMED, JAZZ, and EXEL

Should you be buying Masimo stock or one of its competitors? The main competitors of Masimo include Integer (ITGR), LivaNova (LIVN), TransMedics Group (TMDX), CONMED (CNMD), Inspire Medical Systems (INSP), Viking Therapeutics (VKTX), Intra-Cellular Therapies (ITCI), Globus Medical (GMED), Jazz Pharmaceuticals (JAZZ), and Exelixis (EXEL). These companies are all part of the "medical" sector.

Masimo vs.

Masimo (NASDAQ:MASI) and Integer (NYSE:ITGR) are both mid-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, community ranking, media sentiment, dividends, valuation, analyst recommendations and profitability.

Integer has lower revenue, but higher earnings than Masimo. Integer is trading at a lower price-to-earnings ratio than Masimo, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Masimo$2.05B3.52$81.50M$1.5190.16
Integer$1.60B2.30$90.65M$2.8937.92

Masimo presently has a consensus target price of $137.43, suggesting a potential upside of 0.95%. Integer has a consensus target price of $120.50, suggesting a potential upside of 9.97%. Given Integer's stronger consensus rating and higher possible upside, analysts plainly believe Integer is more favorable than Masimo.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Masimo
0 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.43
Integer
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67

Integer has a net margin of 6.01% compared to Masimo's net margin of 3.98%. Masimo's return on equity of 13.77% beat Integer's return on equity.

Company Net Margins Return on Equity Return on Assets
Masimo3.98% 13.77% 5.98%
Integer 6.01%11.25%5.69%

Masimo received 78 more outperform votes than Integer when rated by MarketBeat users. Likewise, 64.02% of users gave Masimo an outperform vote while only 63.39% of users gave Integer an outperform vote.

CompanyUnderperformOutperform
MasimoOutperform Votes
452
64.02%
Underperform Votes
254
35.98%
IntegerOutperform Votes
374
63.39%
Underperform Votes
216
36.61%

86.0% of Masimo shares are owned by institutional investors. Comparatively, 99.3% of Integer shares are owned by institutional investors. 9.7% of Masimo shares are owned by insiders. Comparatively, 2.0% of Integer shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Integer had 18 more articles in the media than Masimo. MarketBeat recorded 28 mentions for Integer and 10 mentions for Masimo. Masimo's average media sentiment score of 0.64 beat Integer's score of 0.21 indicating that Masimo is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Masimo
3 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Integer
4 Very Positive mention(s)
3 Positive mention(s)
10 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

Masimo has a beta of 0.97, suggesting that its share price is 3% less volatile than the S&P 500. Comparatively, Integer has a beta of 1.1, suggesting that its share price is 10% more volatile than the S&P 500.

Summary

Masimo and Integer tied by winning 9 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MASI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MASI vs. The Competition

MetricMasimoElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$7.20B$2.95B$4.88B$7.55B
Dividend YieldN/A1.76%2.91%3.95%
P/E Ratio90.1614.66232.4819.19
Price / Sales3.5257.462,338.7085.76
Price / Cash23.4652.6447.0434.73
Price / Book5.283.584.764.33
Net Income$81.50M$85.34M$103.54M$214.22M
7 Day Performance1.02%-5.50%0.74%1.88%
1 Month Performance-5.77%-7.44%-7.60%-5.23%
1 Year Performance-27.53%4.08%9.25%8.41%

Masimo Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ITGR
Integer
1.1854 of 5 stars
$117.92
+1.1%
$120.50
+2.2%
+27.5%$3.95B$1.60B43.8410,500Earnings Report
Analyst Report
Short Interest ↑
News Coverage
LIVN
LivaNova
1.6945 of 5 stars
$55.02
+1.9%
$64.40
+17.0%
+16.4%$2.97B$1.15B171.942,900Upcoming Earnings
Analyst Upgrade
News Coverage
TMDX
TransMedics Group
1.0157 of 5 stars
$90.60
+4.7%
$102.00
+12.6%
+17.2%$2.96B$241.62M-117.66584Upcoming Earnings
CNMD
CONMED
4.8868 of 5 stars
$71.31
-1.8%
$120.43
+68.9%
-48.7%$2.20B$1.24B34.964,000Earnings Report
Analyst Report
News Coverage
INSP
Inspire Medical Systems
4.0837 of 5 stars
$234.11
+3.9%
$272.20
+16.3%
-11.7%$7.09B$624.80M-316.361,011Positive News
VKTX
Viking Therapeutics
4.5422 of 5 stars
$64.93
+1.7%
$112.25
+72.9%
+278.9%$7.16BN/A-70.5827Earnings Report
Analyst Report
Analyst Revision
ITCI
Intra-Cellular Therapies
4.4564 of 5 stars
$74.01
-0.7%
$88.58
+19.7%
+18.4%$7.16B$464.37M-50.69610Upcoming Earnings
Analyst Report
Analyst Revision
GMED
Globus Medical
4.8651 of 5 stars
$51.28
+0.1%
$66.33
+29.4%
-12.1%$6.94B$1.02B43.835,000News Coverage
Positive News
JAZZ
Jazz Pharmaceuticals
4.8531 of 5 stars
$109.67
+0.8%
$195.08
+77.9%
-21.3%$6.91B$3.83B17.922,800Upcoming Earnings
News Coverage
EXEL
Exelixis
4.8242 of 5 stars
$23.29
+1.8%
$26.29
+12.9%
+30.4%$6.87B$1.83B36.391,310Upcoming Earnings
Short Interest ↑
Analyst Revision
News Coverage

Related Companies and Tools

This page (NASDAQ:MASI) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners